Recent Advances in Computational Modeling of Thrombosis [PDF]
2019, 2018 The study of thrombosis is crucial to understand and develop new therapies for diseases like deep vein thrombosis, diabetes related strokes, pulmonary embolism etc. The last two decades have seen an exponential growth in studies related to the blood clot formation using computational tools and through experiments.
arxiv +1 more source
Treatment of the acute severe pulmonary embolism using endovascular methods [PDF]
, 2018 Purpose: To present a single-centre experience with endovascular treatment of patients with severe symptoms secondary to acute pulmonary embolism (PE). Material and methods: Twenty-five patients were treated due to contraindications or deficient effects ...
Bursjoo, Carina +2 more
core +1 more source
Frontiers in Neurology, 2018 Background and Purpose: Subgroup analysis of the SAMMPRIS trial showed a higher rate of periprocedural perforator strokes with the Wingspan stent in the basilar artery in patients with symptomatic intracranial atherosclerotic stenosis (ICAS).
Hannes Nordmeyer +11 more
doaj +1 more source
Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism. [PDF]
, 2019 PURPOSE:The purpose of this study is to assess the incremental effect of tissue plasminogen activator (t-PA) dose on pulmonary artery pressure (PAP) and bleeding during catheter directed thrombolysis (CDT) of submassive pulmonary embolism (PE). MATERIALS
Gaba, Ron C +3 more
core +2 more sources
Erciyes Medical Journal, 2019 Behcet's Disease (BD) is an inflammatory vasculitis with multisystem involvement. Typical manifestations such as oral-genital ulcerations, joint, skin, and ocular involvement usually occur during the initial period of the disease, whereas cardiac and ...
Serkan Türkuçar +3 more
doaj +1 more source
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial [PDF]
, 2019 Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage.
Al-Shahi Salman, Rustam +16 more
core +1 more source
Gastrointestinal Bleeding: a Cardiologist's Point of View
Рациональная фармакотерапия в кардиологии, 2021 Oral anticoagulant therapy is widely used in different patients for the prevention and treatment of thromboembolic events: in atrial fibrillation, deep vein thrombosis/pulmonary embolism, acute coronary syndrome, in the early postoperative period after ...
O. V. Averkov, L. N. Mishchenko
doaj +1 more source
Early Placement of Optional Vena Cava Filter in High-Risk Patients with Traumatic Brain Injury [PDF]
, 2015 Objectives:: Patients sustaining severe trauma are at high risk for the development of venous thromboembolic events (VTE). Pharmacologic VTE prophylaxis may be contraindicated early after trauma due to potential bleeding complications.
Meier, Christoph +8 more
core +3 more sources
Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis [PDF]
, 2016 Reviewpublished_or_final_versio
Günther, A, Kwan, SKJ, Price, M
core +1 more source
Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis [PDF]
, 2014 BACKGROUND: Intracranial venous thrombosis (ICVT) commonly presents with seizures in the acute period, and some people may develop recurrent seizures in the long term. The prophylactic use of antiepileptic drugs (AEDs) for the management of post-ICVT
Günther, A, Kwan, SKJ, Price, M
core +1 more source